ArticleScience translational medicine2026

Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

Diana D Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.